Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Shares Jump 7.14 Percent After French Drug Maker Taps Company for Discovery Deal

NEW YORK, Aug. 30 (GenomeWeb News) - Shares in Tripos were up 7.14 percent, or $.29, at $4.35 in mid-afternoon trading today after the company said it will work with a French drug maker to identigy potential drug targets.


Terms of the deal call for Servier to use Tripos' ChemSpace and LeadHopping technology and its chemistry processes to identify chemistries against targets that it had previously uncovered using Tripos' LeadQuest compound collection, the companies said.


Financial terms of the agreement were not disclosed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.